CompletedPhase 2

FST-100 in the Treatment of Acute Viral Conjunctivitis

United States, Brazil132 participantsStarted 2013-05-17

Plain-language summary

This randomized, double masked, multi-center study is being conducted to support the safety and efficacy of FST-100 for the treatment of acute viral conjunctivitis. The study intends to show superiority of FST-100 ophthalmic suspension compared to vehicle for clinical resolution of acute viral conjunctivitis.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Have a clinical diagnosis of suspected acute viral conjunctivitis in at least one eye Exclusion Criteria: * Have a known sensitivity to any of the components of FST-100 or FST-100 vehicle

What they're measuring

Clinical resolution of acute viral conjunctivitis

Timeframe: 6-7 days

Trial details

NCT IDNCT01461954

SponsorShire

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2014-03-10

View on ClinicalTrials.gov More Acute Viral Conjunctivitis trials